Skip to main content
. Author manuscript; available in PMC: 2023 Apr 23.
Published in final edited form as: Transplant Cell Ther. 2020 Dec 16;27(4):308.e1–308.e8. doi: 10.1016/j.jtct.2020.12.010

Figure 2.

Figure 2.

Comparison of biomarkers at time points before the onset of TMA. The mean values and 95% CIs of biomarkers are shown for 13 TA-TMA cases (dark bar) versus 25 non-TMA controls (light bar) at each discrete time point (pretransplantation and onset of aGVHD). Significance differences (*P < .05) were detected for sC5b9 and ANG2 at the onset of aGVHD.